Advanced Search

    Technical Analysis for VXRT - Vaxart, Inc.

    Grade Last Price % Change Price Change
    F 1.00 -6.54% -0.07
    VXRT closed down 6.54 percent on Wednesday, February 8, 2023, on 44 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    Earnings due: Feb 22
    *** please verify all earnings dates ***
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical VXRT trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Centerline Cross Bearish -6.54%
    Crossed Above 50 DMA Bullish -6.54%
    Lizard Bullish Bullish Day Trade Setup -6.54%
    Older End-of-Day Signals for VXRT ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Down 5% about 7 hours ago
    Lower Bollinger Band Support about 7 hours ago
    Fell Below Previous Day's Low about 10 hours ago
    Fell Below Lower Bollinger Band about 10 hours ago
    60 Minute Opening Range Breakdown about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators Basic chart:

    Profile

    Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Influenza Vaccines Coronavirus Vaccination Hepatitis B Papillomavirus Seasonal Influenza HPV Human Papilloma Virus

    Is VXRT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 18 Covid Isn’t Going Away. New Drugs Are Coming.
    Jan 9 Profound Medical (PROF) Surges 5.1%: Is This an Indication of Further Gains?
    Dec 29 Vaxart And 3 Other Stocks Under $1 Insiders Are Aggressively Buying
    Dec 23 Vaxart: Great Potential But Issues Remain
    Dec 19 Vaxart has a new CFO
    Dec 19 Vaxart Names Phillip Lee as Chief Financial Officer
    Dec 1 Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
    Nov 27 Are needle-free COVID vaccines our way out of the pandemic?
    Nov 22 Vaxart to Present at World Vaccine & Immunotherapy Congress West Coast 2022 on November 29
    Nov 11 Vaxart Third Quarter 2022 Earnings: US$0.23 loss per share (vs US$0.14 loss in 3Q 2021)
    See more VXRT news...

    Indicators

    Indicator Value
    52 Week High 5.43
    52 Week Low 0.7316
    Average Volume 3,152,840
    200-Day Moving Average 2.50
    50-Day Moving Average 1.06
    20-Day Moving Average 1.10
    10-Day Moving Average 1.08
    Average True Range 0.08
    RSI 42.20
    ADX 19.82
    +DI 19.00
    -DI 16.10
    Chandelier Exit (Long, 3 ATRs) 1.01
    Chandelier Exit (Short, 3 ATRs) 1.22
    Upper Bollinger Bands 1.20
    Lower Bollinger Band 1.00
    Percent B (%b) 0.0
    BandWidth 17.90
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.0048
    Fundamentals Value
    Market Cap 109.47 Million
    Num Shares 109 Million
    EPS -2.03
    Price-to-Earnings (P/E) Ratio -0.49
    Price-to-Sales 67.33
    Price-to-Book 5.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.11
    Resistance 3 (R3) 1.12 1.09 1.09
    Resistance 2 (R2) 1.09 1.07 1.09 1.08
    Resistance 1 (R1) 1.05 1.05 1.04 1.04 1.08
    Pivot Point 1.02 1.02 1.02 1.02 1.02
    Support 1 (S1) 0.98 1.00 0.97 0.97 0.92
    Support 2 (S2) 0.95 0.98 0.95 0.92
    Support 3 (S3) 0.91 0.95 0.91
    Support 4 (S4) 0.90